NMRK2 and breast cancer: Moreover, MEP, MEHHP, MEHP, MEOHP, MBP, and MiBP were not significantly associated with breast cancer risk in the subgroups (Table 4, Table 5, Table 6 and Table 7, Table 9, and Table 10).